Oxford Global鈥檚 8th Annual Proteins and Antibodies Congress is Europe鈥檚 leading Congress in the field, bringing together over 350 senior-level decision makers working at the forefront of research into protein expression, purification and antibody therapeutics in Europe and the US.
The conference programme consists of four interactive streams:
鈥� Protein Purification and Downstream Processing
鈥� Antibody Discovery and Engineering
鈥� Protein Expression and Characterisation
鈥� Therapeutic Antibodies and Alternative Scaffolds
On day one our panel of protein experts will discuss how to overcome purification bottlenecks and optimize current purification processes. Our dedicated antibodies stream will showcase novel antibody library design technology, advances in cellular display platforms and effective antibody lead selection methods.
Day two features presentations about protein expression and characterisation challenges, including CHO cell engineering, biophysical characterisation challenges and novel technologies for characterisation such as protein labelling and HDX mass spectrometry. Delegates will also hear from our panel of key antibody industry leaders about their current antibody therapeutics projects.
Building on the success of previous years, our exciting Congress will be co-located with the 3rd Annual Biosimilars and Biobetters Congress and 2nd Annual Peptides Congress. Delegates are able to access all of the presentations at the three co-located Congresses, maximising their learning and networking opportunities.
The conference programme consists of four interactive streams:
鈥� Protein Purification and Downstream Processing
鈥� Antibody Discovery and Engineering
鈥� Protein Expression and Characterisation
鈥� Therapeutic Antibodies and Alternative Scaffolds
On day one our panel of protein experts will discuss how to overcome purification bottlenecks and optimize current purification processes. Our dedicated antibodies stream will showcase novel antibody library design technology, advances in cellular display platforms and effective antibody lead selection methods.
Day two features presentations about protein expression and characterisation challenges, including CHO cell engineering, biophysical characterisation challenges and novel technologies for characterisation such as protein labelling and HDX mass spectrometry. Delegates will also hear from our panel of key antibody industry leaders about their current antibody therapeutics projects.
Building on the success of previous years, our exciting Congress will be co-located with the 3rd Annual Biosimilars and Biobetters Congress and 2nd Annual Peptides Congress. Delegates are able to access all of the presentations at the three co-located Congresses, maximising their learning and networking opportunities.
